Stakeholder views on participant selection for first-in-human trials in cancer nanomedicine

P. Satalkar, B. S. Elger, D. M. Shaw

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)E530-E537
JournalCurrent Oncology
Volume23
Issue number6
DOIs
Publication statusPublished - Dec 2016

Keywords

  • First-in-human trials
  • trial participant selection
  • nanomedicine
  • qualitative research
  • empirical ethics

Cite this